Literature DB >> 2278053

Future prospects for the chemotherapy of human trypanosomiasis. 1. Novel approaches to the chemotherapy of trypanosomiasis.

A H Fairlamb1.   

Abstract

Chemotherapy of trypanosomiasis and leishmaniasis is far from satisfactory and the discovery of new drugs has been slow. Emphasis on the empirical approach to drug development is now shifting towards a more rational, directed approach, which employs the modern tools of science. This is illustrated with respect to the newly discovered drug target, trypanothione, a unique metabolite which is critical for survival of Trypanosoma and Leishmania and absent from the host.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2278053     DOI: 10.1016/0035-9203(90)90124-w

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  6 in total

1.  High-efficiency clonal growth of bloodstream- and insect-form Trypanosoma brucei on agarose plates.

Authors:  V B Carruthers; G A Cross
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

Review 2.  Human African trypanosomiasis of the CNS: current issues and challenges.

Authors:  Peter G E Kennedy
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

Review 3.  Polyamines. An overview.

Authors:  D M Morgan
Journal:  Mol Biotechnol       Date:  1999-06       Impact factor: 2.695

Review 4.  Human African trypanosomiasis-neurological aspects.

Authors:  Peter G E Kennedy
Journal:  J Neurol       Date:  2006-03-20       Impact factor: 4.849

5.  In vitro study of anticancer acridines as potential antitrypanosomal and antimalarial agents.

Authors:  D Figgitt; W Denny; P Chavalitshewinkoon; P Wilairat; R Ralph
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

Review 6.  Parasitic pneumonia and lung involvement.

Authors:  Attapon Cheepsattayakorn; Ruangrong Cheepsattayakorn
Journal:  Biomed Res Int       Date:  2014-06-09       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.